{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:00:51Z","timestamp":1792119651904,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejca.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T17:49:44Z","timestamp":1646934584000},"page":"60-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Genetic characterization of advanced conjunctival melanoma and response to systemic treatment"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6930-2694","authenticated-orcid":false,"given":"Georg C.","family":"Lodde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2753-9626","authenticated-orcid":false,"given":"Antje","family":"Sucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Hassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-4945","authenticated-orcid":false,"given":"Andrea","family":"Forschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedegund","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina C.","family":"K\u00e4hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Ziemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Schlaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7607-8152","authenticated-orcid":false,"given":"Kerstin","family":"Schatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4044-9094","authenticated-orcid":false,"given":"Frank","family":"Meiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7921-2820","authenticated-orcid":false,"given":"Ralf","family":"Gutzmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0384-114X","authenticated-orcid":false,"given":"Claudia","family":"Pf\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5894-1677","authenticated-orcid":false,"given":"Patrick","family":"Terheyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8859-4103","authenticated-orcid":false,"given":"Bastian","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sachse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus V.","family":"Heppt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-0047","authenticated-orcid":false,"given":"Anca","family":"Sindrilaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Zaremba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl M.","family":"Thielmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Ugurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3680-3521","authenticated-orcid":false,"given":"Lisa","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-5963","authenticated-orcid":false,"given":"Eva","family":"Hadaschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos E.","family":"Bechrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3524-7858","authenticated-orcid":false,"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Westekemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8279-9239","authenticated-orcid":false,"given":"Elisabeth","family":"Livingstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3899-9449","authenticated-orcid":false,"given":"Klaus G.","family":"Griewank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ejca.2022.01.008_bib1","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ejca.2022.01.008_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2022.01.008_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2217\/fon.11.12","article-title":"Current appraisal of conjunctival melanocytic tumors: classification and treatment","volume":"7","author":"Harooni","year":"2011","journal-title":"Future Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2022.01.008_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/ICU.0b013e32833b7aab","article-title":"Conjunctival melanoma: pitfalls and dilemmas in management","volume":"21","author":"Shildkrot","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ejca.2022.01.008_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ajo.2007.10.022","article-title":"Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas","volume":"145","author":"Hu","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ejca.2022.01.008_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/107327481602300205","article-title":"Management of primary acquired melanosis, nevus, and conjunctival melanoma","volume":"23","author":"Kao","year":"2016","journal-title":"Cancer Control"},{"issue":"11","key":"10.1016\/j.ejca.2022.01.008_bib7","first-page":"3399","article-title":"Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites","volume":"43","author":"Tuomaala","year":"2002","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ejca.2022.01.008_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ophtha.2010.06.021","article-title":"Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ejca.2022.01.008_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1167\/iovs.04-0344","article-title":"Conjunctival melanoma in The Netherlands: a nationwide study","volume":"46","author":"Missotten","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ejca.2022.01.008_bib10","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/archopht.118.11.1497","article-title":"Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients","volume":"118","author":"Shields","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ejca.2022.01.008_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.86.2.163","article-title":"Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study","volume":"86","author":"Anastassiou","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ejca.2022.01.008_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ophtha.2003.11.001","article-title":"Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy","volume":"111","author":"Tuomaala","year":"2004","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ejca.2022.01.008_bib13","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","article-title":"Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas","volume":"19","author":"Griewank","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ejca.2022.01.008_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.2013.312","article-title":"TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours","volume":"109","author":"Griewank","year":"2013","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2022.01.008_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41416-018-0046-5","article-title":"NF1 mutations in conjunctival melanoma","volume":"118","author":"Scholz","year":"2018","journal-title":"Br J Cancer"},{"issue":"15","key":"10.1016\/j.ejca.2022.01.008_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153836","article-title":"Definition of biologically distinct groups of conjunctival melanomas according to etiological factors and implications for precision medicine","volume":"13","author":"Gardrat","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejca.2022.01.008_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40425-019-0555-7","article-title":"Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series","volume":"7","author":"Finger","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2022.01.008_bib18","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jamaophthalmol.2018.3488","article-title":"Immunotherapy with programmed cell death 1 inhibitors for 5 patients with conjunctival melanoma","volume":"136","author":"Sagiv","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.ejca.2022.01.008_bib19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.ejca.2022.01.008_bib20","series-title":"R. A language and environment for statistical computing","author":"Team","year":"2020"},{"key":"10.1016\/j.ejca.2022.01.008_bib21","series-title":"RStudio","author":"Team","year":"2019"},{"issue":"7278","key":"10.1016\/j.ejca.2022.01.008_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature08658","article-title":"A comprehensive catalogue of somatic mutations from a human cancer genome","volume":"463","author":"Pleasance","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejca.2022.01.008_bib23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1470-2045(20)30062-0","article-title":"Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial","volume":"21","author":"Dummer","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2022.01.008_bib24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1158\/2326-6066.CIR-20-0983","article-title":"TMB and inflammatory gene expression associated with clinical outcomes following immunotherapy in advanced melanoma","volume":"9","author":"Hodi","year":"2021","journal-title":"Cancer Immunol Res"},{"issue":"11","key":"10.1016\/j.ejca.2022.01.008_bib25","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","article-title":"Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma","volume":"24","author":"Blank","year":"2018","journal-title":"Nat Med"},{"issue":"10030","key":"10.1016\/j.ejca.2022.01.008_bib26","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0140-6736(16)00587-0","article-title":"Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial","volume":"387","author":"Fehrenbacher","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2022.01.008_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejca.2021.09.044","article-title":"Cutaneous melanoma attributable to UVR exposure in Denmark and Germany","volume":"159","author":"Keim","year":"2021","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2022.01.008_bib28","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/s41467-020-16276-8","article-title":"Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours","volume":"11","author":"Johansson","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ejca.2022.01.008_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.ejca.2022.01.008_bib30","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ejca.2022.01.008_bib31","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1038\/s41467-019-11107-x","article-title":"Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets","volume":"10","author":"Newell","year":"2019","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ejca.2022.01.008_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081133","article-title":"Atypical BRAF and NRAS mutations in mucosal melanoma","volume":"11","author":"Dumaz","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ejca.2022.01.008_bib33","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jhep.2020.07.026","article-title":"Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma","volume":"73","author":"Sangro","year":"2020","journal-title":"J Hepatol"},{"issue":"16","key":"10.1016\/j.ejca.2022.01.008_bib34","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.01.008_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejca.2021.08.034","article-title":"Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: a retrospective, multicenter study","volume":"157","author":"Umeda","year":"2021","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2022.01.008_bib36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3892\/mco.2016.1037","article-title":"Clinical presentation and management of uveal melanoma (Review)","volume":"5","author":"Rodr\u00edguez","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ejca.2022.01.008_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2021.07.028","article-title":"Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases","volume":"156","author":"Hilbers","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.01.008_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2021.05.031","volume":"154","author":"Saiag","year":"2021","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2022.01.008_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2022.01.008_bib40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11060-015-2052-2","article-title":"Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system","volume":"127","author":"van de Nes","year":"2016","journal-title":"J Neuro Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:35:18Z","timestamp":1760733318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":40,"alternative-id":["S0959804922000247"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.01.008","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic characterization of advanced conjunctival melanoma and response to systemic treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}